Coherence platform
undisclosedEnable feasible in vivo target screening for age-related diseases by collecting and synthesizing biological data and supporting interpretation of complex biologic data.
Machine learning, bioinformatics, a proprietary knowledge database, and deep learning models applied to in vivo target screening data.
Arrive states it has developed the Coherence platform/system for in vivo target screening and complex biologic data interpretation.
